Because 90% of the drug is released in the intestine and not into the bloodstream, it causes fewer side effects than other corticosteroids (such as prednisone). Entocort EC (budesonide ...

It is an alternative to prednisolone. Due to its high first-pass metabolism in the liver, budesonide causes fewer systemic side-effects. Increasing use of budesonide in IBD and other immunological ...

Background—The use of corticosteroids in active Crohn’s disease often becomes limited by side effects. Budesonide is a potent corticosteroid with low systemic bioavailability due to an extensive first ...

Iatrogenic adrenal insufficiency is a potential harmful side effect of treatment with corticosteroids ... developed an Addisonian crisis after inappropriate discontinuation of budesonide (a topical ...

Budesonide, coupled with a colonic release system (MMX Multi-Matrix System) has demonstrated promising clinical efficacy in UC, while minimising systemic side effects. Here, we have investigated the ...

There was no evidence that budesonide provided a different pattern of symptom control from prednisolone, or that symptoms became worse than placebo treatment levels after discontinuation of ...

The cost of nebulised budesonide was estimated to be 1.7–3.5 times higher than that of inhaled fluticasone administered by metered dose inhaler. There is a great deal of available information about ...

BACKGROUND The potential for long term adverse effects from inhaled corticosteroids relates to their systemic absorption, usually assessed from proxy markers in short term studies. When fluticasone ...

AIMS To determine whether nebulised budesonide improves the symptoms or shortens the duration of stay of children admitted to hospital with a clinical diagnosis of croup. METHODS A prospective, ...